MEDS will publish its interim report for the third quarter on November 6, 2026, at 07:30 CET. A webcast presentation will be held for analysts, media, and investors at 10:00 CET the same day.

The report will be presented by Björn Thorngren, CEO and co-founder, and Nick Mendola, CFO.

The presentation will be conducted in English and broadcast live online. Please email ir@meds.se to receive a link to the live presentation (at latest 09:30 CET on November 6).

A recorded version of the presentation will be available later at: 

Rapporter och presentationer | MEDS Investor Relations

Schedule for the 6th of November:

  • 07:30 CET – Publication of the Q3 report
  • 10:00 CET – Webcast and conference call with CEO Björn Thorngren and CFO Nick Mendola

For further information, please contact:
MEDS Investor Relations
E-mail: ir@meds.se
Web: https://corporate.meds.se/

About MEDS
MEDS.se is a full-scale online pharmacy licensed by the Swedish Medical Products Agency. We provide both prescription and over-the-counter medicines for you, your family, and your pets.
In addition, MEDS offers a wide range of products in health, beauty, and wellness.

Certified advisor is FNCA.

Attachments

Invitation to presentation of MEDS Q3 2026 Interim Report on November 6, 2026

Läs mer på MFN

Ämnen i artikeln


Meds Apotek

Senast

23,00

1 dag %

0,00%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån